Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-0200 in NAFLD
NCT02546609Phase 2Completed
- Sponsor
- NuSirt Biopharma
- Start
- Nov 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-leucine, metformin, sildenafil in non-alcoholic fatty liver disease (NAFLD), sponsored by NuSirt Biopharma. Started Nov 2015; status: completed.
02
Drugs
l-leucinemetforminsildenafil
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02546609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546609.